Nikon 2013 Annual Report Download - page 12

Download and view the complete annual report

Please find page 12 of the 2013 Nikon annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 68

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68

10
Consolidated Financial Targets
Years ended/ending March 31
(Billions of yen) 2013 (Actual) 2014 2016
Assumed Exchange Rates
2013 U.S.$1 = ¥83 1 euro = ¥107
2014 U.S.$1 = ¥95 1 euro = ¥125
2016 U.S.$1 = ¥95 1 euro = ¥125
(Announced on May 9, 2013)
Net Sales 1,010.4 1,110.0 1,300.0
Operating Income 51.0 85.0 170.0
Net Income 42.4 65.0 110.0
Another essential element of the Medium
Term Management Plan is new business.
Could you provide an overview of this?
While the main target for new business is the field
of health and medical-related areas, the plan makes
clear our intention to focus particularly on the areas
of diagnosis and analysis. Yet, even within this focus
area, the projects we are pursuing cover a broad
spectrum of development stages. Some projects
need to begin with basic technology development,
while others—although somewhat advanced in
terms of technology development—are at the
stage of analyzing the steps needed to engage the
potential market. We anticipate that the earliest
products to be launched will generate a certain
level of sales by the fiscal year ending March 2016,
while those requiring the longest lead time may
take a further five years to reach commercialization.
We expect the medical field to undergo significant
changes, particularly as we hear many domestic and
overseas government officials say that the rapid rise
in healthcare costs is leading to a serious situation.
We want to help alleviate this situation by developing
new methods of diagnosis and analysis that can
contribute to the provision of efficient medical
treatment. By leveraging Nikon’s technologies—
optics, precision control, image processing and
inspection—we plan to cultivate new businesses
based on a theme of developing equipment and
systems in such areas as image analysis and
diagnostic support at the genetic and cellular levels,
and support for appropriate treatments and new
drug development.
Nikon’s CSR-related policy states,
“We recognize the importance of CSR
and will contribute to the sustainable
development of society.” Please summarize
what this involves.
We believe that, as a company, we contribute to
the development of society through our steady
growth and creation of value. Nikon is involved in
business activities worldwide, and we maintain
facilities and offices in a large number of countries.
I want the Nikon Group to become firmly rooted in
each of the communities in which we operate. By
becoming an integral part of those communities, we
will be able to contribute more to those societies.
This is one of the reasons that it is so important
for the Nikon Group to become more international
as an organization, and to pursue a localization
strategy. Another core factor of corporate social
responsibility policy is our duty to humanity and
the environment. The pursuit of profit alone will
ultimately lead to failure. Hence, we conduct our
business activities based on the premise that we
must maintain harmony with society.